Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T62611 |
Adenosine receptor antagonist 2
|
||
Adenosine receptor antagonist 2 是一种具有口服活性的 A2a (IC50: 1 nM) /A2b (IC50: 3 nM) 腺苷受体拮抗剂。Adenosine receptor antagonist 2 表现出抗肿瘤效果。 | |||
T21620 |
Adenosine receptor antagonist 4
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
Adenosine receptor antagonist 4 是一种腺苷受体拮抗剂。 | |||
T37793 |
A2B receptor antagonist 2
A2B receptor antagonist 2 |
Adenosine Receptor | GPCR/G Protein; Neuroscience |
A2B receptor antagonist 2 是腺苷受体 A2B 的拮抗剂(rA1 的 Ki = 2.30 μM,rA2A 的 Ki = 6.8 μM,hA2B 的 3.44 μM)。 | |||
T77508 |
A2B receptor antagonist 2 hydrochloride
|
||
A2B receptor antagonist 2 hydrochloride 是腺苷受体 A2B 的拮抗剂(rA1 的 Ki = 2.30 μM,rA2A 的 Ki = 6.8 μM,hA2B 的 3.44 μM) | |||
T16811 |
RWJ-51204
|
GABA Receptor | Membrane transporter/Ion channel; Neuroscience |
RWJ-51204是选择性的腺苷 A2A 受体拮抗剂, 是 GABA(A) receptor 的部分激动剂(IC50: 0.2-2 nM)。其具有神经保护和改善运动的功效,可用于帕金森疾病的相关研究。 | |||
T22031 |
ANR 94
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
ANR94 是一种有效的、选择性的腺苷 A2A 受体 (AA2AR) 拮抗剂,对 hAA2AR 的Ki 值为 46 nM。ANR94 具有用于帕金森病的研究潜力。 | |||
T25840 |
MSX-2
MSX 2 |
||
MSX-2 is an A2A adenosine receptor antagonist. | |||
T25841 |
MSX-3
MSX 3 |
||
MSX-3 is an antagonist of the A2A adenosine receptor and a prodrug of MSX-2. | |||
T63326 |
A2A receptor antagonist 2
|
||
A2A receptor antagonist 2 是高度选择性的 adenosine A2Areceptor 的有效拮抗剂 (IC50: 8.3 nM)。 | |||
T69566 | MSX-3 free acid | ||
MSX-3 free acid is an A2A adenosine receptor antagonist and a prodrug of MSX-2. | |||
T72588 |
A3AR antagonist 2
|
||
A3AR antagonist 2 是一种有效的人 A3 腺苷受体 (A3adenosine receptor) 拮抗剂,Ki 值为 4.54 nM . | |||
T60580 |
A1AR antagonist 2
|
||
A1AR antagonist 2 (compound 18h) 是 A1腺苷受体 (A1 adenosine receptor) 的有效的选择性拮抗剂。A1AR antagonist 2对于 hA1, hA2A,hA2B 的Ki 值分别为 1.49、10.2 和 50.1 nM。 | |||
T70770 |
Cyclazosin Free Base
|
||
Cyclazosin Free Base is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of furoic acid with the secondary amino group of 6,7-dimethoxy-2-[(4aR,8aS)-octahydroquinoxalin-1-yl]quinazolin-4-amine. It has a role as an adenosine A2A receptor antagonist. It is a member of quinazolines, a member of furans, an aromatic ether, a quinoxaline derivative, an aromatic amide and a monocarboxylic acid amide. | |||
T72626 |
A2AR-antagonist-1
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
A2AR-antagonist-1 (compound 38) 为一种口服活性的腺苷 A2A 受体 (A2AR) 拮抗剂,IC50 值为 29 nM。此化合物展示出抗肿瘤作用,并在小鼠肝微粒体中表现出良好的代谢稳定性,半衰期为 86.1 分钟。同时,A2AR-antagonist-1 能够作为 T 细胞激活剂,通过抑制免疫抑制分子 LAG-3 和 TIM-3,以及增强 GZMB、IFNG 和 IL-2 等效应分子的表达。 | |||
T60511 |
Theophylline sodium glycinate
|
||
Theophylline (1,3-Dimethylxanthine) sodium glycinate 是一种有效的磷酸二酯酶 (PDE) 抑制剂,可抑制 PDE3 活性以松弛气道平滑肌。Theophylline sodium glycinate 可用于研究哮喘和慢性阻塞性肺疾病 (COPD) 。Theophylline sodium glycinate 也是一种腺苷受体拮抗剂和组蛋白脱乙酰酶 (HDAC) 激活剂。 Theophylline sodium glycinate 通过增加 IL-10 和抑制 NF-κB 的核输入而具有抗炎活性。Theophyllin sodium glycinate 可诱导细胞凋亡。 | |||
T36679 |
Rp-cAMPS sodium salt
|
||
Rp-cAMPS sodium salt, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 μM and 4.5 μM, respectively) antagonist. Rp-cAMPS sodium salt is resistant to hydrolysis by phosphodiesterases[1][2][3][4][5][6]. A membrane-permeable competitive cAMP antagonist (Rp-cAMPS) that blocks PKA activation by binding to the regulatory subunits without dissociating the kinase holoenzyme also inhibits synaptic plasticity but has no effect on normal synaptic t... |